CGTN AMERICA & CCTV UN: Global Dialogue on Innovation, Openness and Shared Development
WASHINGTON, Oct. 23, 2025 /PRNewswire/ -- CGTN America & CCTV UN releases…
IndiaWorks Energy: Powering Germany’s Green Transition with India’s Skilled Workforce
FREIBURG, Germany and NOIDA, India, Oct. 24, 2025 /PRNewswire/ -- In a…
MindHYVE.ai and Prime Institute of Health Sciences (PIHS) Launch Landmark AI Partnership to Transform Education and Healthcare in Pakistan
ISLAMABAD, Oct. 24, 2025 /PRNewswire/ -- MindHYVE.ai™, a global leader in agentic…
K12 Wins Two Silver Medals at 2025 International Serious Play Awards
RESTON, VA, Oct. 24, 2025 (GLOBE NEWSWIRE) -- K12, a national leader…
Hera & Circular Revolutionize Traceability & Transparency in Banking, Insurance, Agri-food, and Healthcare
Washington D.C., Oct. 24, 2025 (GLOBE NEWSWIRE) -- The strategic partnership between…
Surfshark launches a privacy-first web content blocker
Surfshark, a cybersecurity company, launches a new feature called the web content…
Questex’s IHIF Asia Delivers Record Deal-Making Activity as $280B in Capital Targets APAC Hotel Market
Major Acquisition Deal Originated at 2024 Event Highlights Conference's Role as Premier…
Flare Therapeutics Presents Part A Data from FX-909 Phase 1 Study at AACR-NCI-EORTC International Conference
October 24, 2025 12:00 ET | Source: Flare Therapeutics Inc. FX-909, the…
Quanta Therapeutics Presents Positive Phase 1 Data for QTX3034, an Oral G12D-Preferring Multi-KRAS Inhibitor, in Patients with Advanced Solid Tumors
– QTX3034 monotherapy and the QTX3034-cetuximab combination demonstrated favorable safety profiles and…
PMV Pharmaceuticals Announces Updated Rezatapopt Monotherapy Interim Data From Ongoing PYNNACLE Phase 2 Trial Across Multiple Solid Tumors With a TP53 Y220C Mutation
October 24, 2025 11:39 ET | Source: PMV Pharmaceuticals, Inc. Data presented…
